Steven Gillis - Feb 16, 2022 Form 4 Insider Report for Codiak BioSciences, Inc. (CDAKQ)

Role
Director
Signature
/s/ Yalonda Howze, Attorney-in-Fact for Steven Gillis
Stock symbol
CDAKQ
Transactions as of
Feb 16, 2022
Transactions value $
$0
Form type
4
Date filed
2/18/2022, 03:06 PM
Previous filing
Jan 31, 2022
Next filing
Jun 17, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 On February 16, 2022, the reporting person was granted 8,750 restricted stock units, which vest on the first anniversary of the grant date.